Juul gave presentations in schools to kids—and the FDA is fuming

Ars Technica » Scientific Method 2019-09-10

WASHINGTON, DC - JULY 25: A young man wears a shirt that reads DITCHJUUL while James Monsees, co-founder and chief product officer at JUUL Labs Inc., testifies before the House Economic and Consumer Policy Subcommittee, which is examining JUUL's role in the youth nicotine epidemic, on July 25, 2019 in Washington, DC. (Photo by Mark Wilson/Getty Images)

Enlarge / WASHINGTON, DC - JULY 25: A young man wears a shirt that reads DITCHJUUL while James Monsees, co-founder and chief product officer at JUUL Labs Inc., testifies before the House Economic and Consumer Policy Subcommittee, which is examining JUUL's role in the youth nicotine epidemic, on July 25, 2019 in Washington, DC. (Photo by Mark Wilson/Getty Images) (credit: Getty | Mark Wilson)

The Food and Drug Administration on Monday came out swinging at e-cigarette giant Juul over a variety of its unproven safety claims and startling marketing practices—most notably saying without evidence that its products are safer than smoking traditional cigarettes and giving presentations directly to kids in schools—in at least one alleged case, without teachers present or parental consent.

“Regardless of where products like e-cigarettes fall on the continuum of tobacco product risk, the law is clear that, before marketing tobacco products for reduced risk, companies must demonstrate with scientific evidence that their specific product does in fact pose less risk or is less harmful,” acting FDA Commissioner Dr. Ned Sharpless said in a statement Monday. “JUUL has ignored the law, and very concerningly, has made some of these statements in school to our nation’s youth.”

In response, the agency sent Juul a warning letter over unauthorized marketing as well as a letter of concern (PDF), which included a request for reams of documents “regarding JUUL’s marketing, advertising, promotional, and education campaigns, as well as certain product development activity.”

Read 13 remaining paragraphs | Comments